Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/13/2010US20100119559 Dosage forms of risedronate
05/13/2010US20100119558 Ngna compositions and methods of use
05/13/2010US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer
05/13/2010US20100119554 Transplants
05/13/2010US20100119542 Food extracts for treatment of lipoprotein abnormalities and skin diseases and skin disorders
05/13/2010US20100119525 Method for extending longevity using npc1l1 antagonists
05/13/2010US20100119522 Combination therapy for the treatment of ocular neovascular disorders
05/13/2010US20100119519 Ophthalmic drug delivery system and method
05/13/2010US20100119518 Target for breast cancer therapy and/or diagnosis
05/13/2010US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
05/13/2010US20100119512 Methods of diagnosing, treating, and preventing increased vascular permeability
05/13/2010US20100119510 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
05/13/2010US20100119508 Phenylacetic acid inhibitors of cyclooxygenase
05/13/2010US20100119505 Estrogen Related Receptor, ERRalpha, A Regulator of Bone Formation
05/13/2010US20100119504 Marker Sequences for Labour
05/13/2010US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
05/13/2010US20100119499 Stilbene-based compositions and methods of use therefor
05/13/2010US20100119494 Methods and compositions related to modulating the extracellular stem cell environment
05/13/2010US20100119482 Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase
05/13/2010US20100119481 5,6-dihydro-1h-pyridin-2-one compounds
05/13/2010US20100119480 Methods for treating multiple sclerosis using antisense oligonucleotides
05/13/2010US20100119479 Therapeutic antiviral peptides
05/13/2010US20100119475 Novel inhibitors of glutaminyl cyclase
05/13/2010US20100119472 Composition for combating epistaxis
05/13/2010US20100119471 Mycoplasma hyopneumoniae bacterin vaccine
05/13/2010US20100119445 Plexin d1 as a target for tumor diagnosis and therapy
05/12/2010EP2184353A1 Treatment of influenza
05/12/2010EP2184352A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer
05/12/2010EP2184296A1 Fibroblast growth factor (fgf23) and methods for use
05/12/2010EP2184285A1 Heterocyclic compound and use thereof
05/12/2010EP2184284A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as the active ingredient
05/12/2010EP2184283A1 Process for preparing compounds useful as intermediates for the preparation of modulators of chemokine receptor activity
05/12/2010EP2184282A1 Novel salt of isoquinoline compound and crystal thereof
05/12/2010EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators
05/12/2010EP2184279A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
05/12/2010EP2184278A1 P2x4 receptor antagonist
05/12/2010EP2184277A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof
05/12/2010EP2184276A1 Process to prepare new substituted 1H-Benzo(d) imidazol-2(3h)-Ones, New intermediates and their use as bace 1 inhibitors
05/12/2010EP2184273A1 Halogen substituted compounds as pesticides
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2184073A1 Therapeutic agent for cancer with resistance to protease inhibitor
05/12/2010EP2184067A1 Severe acute respiratory syndrome DNA vaccine compositions and methods of use
05/12/2010EP2184066A1 Injection, injection solution and injection kit preparation
05/12/2010EP2184065A1 Use of ivabradine as a diagnostic agent in the coronary angiography method using multi-cut computed tomography
05/12/2010EP2184064A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof
05/12/2010EP2184063A1 The use of leonurine and compositions thereof
05/12/2010EP2184062A1 Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators
05/12/2010EP2184061A1 Genariol as bacterial efflux pump inhibitor
05/12/2010EP2184060A1 Infant formula compositions containing lutein and zeaxanthin
05/12/2010EP2184059A2 Ion binding polymers and uses thereof
05/12/2010EP2184058A1 Drug coating providing high drug loading and methods for providing the same
05/12/2010EP2184057A1 Medicinal tablet with prolonged release of the active agent
05/12/2010EP2184055A1 Process for preparing solid dosage forms of rosiglitazone maleate
05/12/2010EP2183593A1 Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
05/12/2010EP2183393A1 Microrna signatures in human ovarian cancer
05/12/2010EP2183365A2 Sidna against hepatitis c virus (hcv)
05/12/2010EP2183267A2 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl) nonyl]estra-1,3,5(10)-triene-3,17-beta-diol
05/12/2010EP2183265A1 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a derivatives and their use for the treatment of malaria
05/12/2010EP2183261A1 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
05/12/2010EP2183260A1 Phosphadiazine hcv polymerase inhibitors iv
05/12/2010EP2183258A2 Thiophosphi(o)nic acid derivatives and their use as agonists or antagonists for metabotropic glutamate receptors
05/12/2010EP2183256A1 Therapeutic compounds
05/12/2010EP2183254A1 Inhibitors of protein tyrosine kinase activity
05/12/2010EP2183253A1 Thieno-pyridine derivatives as mek inhibitors
05/12/2010EP2183252A2 Compounds for the treatment of hepatitis c
05/12/2010EP2183251A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers
05/12/2010EP2183250A1 Naphthyridine derivatives as potassium channel modulators
05/12/2010EP2183249A1 8-azabicycloý3.2.1¨octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
05/12/2010EP2183248A2 Benzimidazole poly (adp ribose) polymerase inhibitors
05/12/2010EP2183247A1 New crystalline forms of 2 -hydroxy- 3- ý5- (morpholin- 4- ylmethyl) pyridin-2-yl¨ih- indole- 5 -carbonitrile citrate
05/12/2010EP2183246A2 2-aza-bicyclo-[3.3.0]-octane derivatives
05/12/2010EP2183245A2 Dual modulators of 5-ht2a and d3 receptors
05/12/2010EP2183244A1 Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
05/12/2010EP2183243A2 Pyrazole compounds and their use as raf inhibitors
05/12/2010EP2183242A2 Pyrimidine derivatives 934
05/12/2010EP2183241A2 2-pyridine carboxamide derivatives as sodium channel modulators
05/12/2010EP2183239A1 Sulfonamides as trpm8 modulators
05/12/2010EP2183237A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
05/12/2010EP2183233A1 Dithiazolidine and thiazolidine derivatives as anticancer agents
05/12/2010EP2183232A2 Pi3 kinase modulators and methods of use
05/12/2010EP2183230A1 Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours
05/12/2010EP2183228A1 CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1
05/12/2010EP2183227A1 1, 2, 4 -triazole derivatives as serotonergic modulators
05/12/2010EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/12/2010EP2183224A1 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
05/12/2010EP2183223A2 Metabolites and derivatives of ambrisentan
05/12/2010EP2183222A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
05/12/2010EP2183221A1 New compounds as hsp90 inhibitors
05/12/2010EP2183218A2 Novel b1 antagonists
05/12/2010EP2183216A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
05/12/2010EP2183214A1 Crystalline teglicar
05/12/2010EP2183027A1 Organic compounds
05/12/2010EP2182970A1 A memory influencing protein
05/12/2010EP2182959A1 Composition and treatment
05/12/2010EP2182957A2 Phosphorylated pyrone analogs and methods
05/12/2010EP2182956A2 Salicylanilide modified peptides for use as oral therapeutics
05/12/2010EP2182955A2 Method of manufacture of compressed pharmaceutical formulation containing tibolone
05/12/2010EP2182954A1 Use of nor-bile acids in the treatment of arteriosclerosis
05/12/2010EP2182953A2 New pyrazol derivatives
05/12/2010EP2182952A1 Treatment of post-traumatic stress disorder
1 ... 2271 2272 2273 2274 2275 2276 2277 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 ... 7860